Last quarter (Q4 2022), Avecho Biotechnology Limited's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Avecho Biotechnology Limited's net income was $―. See Avecho Biotechnology Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ ―	$ 1.21M	$ 793.60K	$ 384.63K	$ 4.24M	$ 1.25M
Cost of Revenue	$ ―	$ 336.14K	$ 285.66K	$ 143.72K	$ 214.57K	$ 553.32K
Gross Profit	$ ―	$ 870.02K	$ 507.94K	$ 240.91K	$ 4.02M	$ 698.99K
Operating Expense	$ ―	$ 3.86M	$ 5.06M	$ 3.65M	$ 3.52M	$ 6.02M
Operating Income	$ ―	$ -2.99M	$ -4.55M	$ -3.41M	$ 502.30K	$ -5.33M
Net Non Operating Interest Income Expense	$ ―	$ -2.00K	$ -9.44K	$ -5.13K	$ -2.66K	$ 42.27K
Other Income Expense	$ ―	$ 646.57K	$ 1.14M	$ 777.30K	$ 350.31K	$ 1.29M
Pretax Income	$ ―	$ -2.34M	$ -3.42M	$ -2.63M	$ 849.96K	$ -3.99M
Tax Provision	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ ―	$ -2.34M	$ -3.42M	$ -2.63M	$ 849.96K	$ -3.99M
Basic EPS	$ ―	$ >-0.01	$ >-0.01	$ >-0.01	$ <0.01	$ ―
Diluted EPS	$ ―	$ >-0.01	$ >-0.01	$ >-0.01	$ <0.01	$ ―
Basic Average Shares	$ ―	$ 1.84B	$ 1.80B	$ 1.59B	$ 1.58B	$ ―
Diluted Average Shares	$ ―	$ 1.84B	$ 1.80B	$ 1.59B	$ 1.58B	$ ―
Dividend Per Share	$ ―	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ ―	$ -2.34M	$ -3.42M	$ -2.63M	$ 849.96K	$ -3.99M
Normalized Income	$ ―	$ -2.34M	$ -3.42M	$ -2.63M	$ 958.57K	$ -3.83M
Interest Expense	$ ―	$ 6.35K	$ 9.97K	$ 5.92K	$ 11.03K	$ ―
EBIT	$ ―	$ -2.34M	$ -3.41M	$ -2.63M	$ 860.99K	$ -5.33M
EBITDA	$ ―	$ -2.11M	$ -2.98M	$ -2.09M	$ 1.54M	$ -4.60M

Currency in USD

Avecho Biotechnology Limited Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing